Sclerostin and DKK1 can competitively bind to LRP5/6, a co-receptor in the Wnt signaling pathway, and inactivate it by regulating the transcription of downstream target genes, eventually inducing osteoporosis. This evidence concerns the gene SOST and osteoporosis.